{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:52:59Z","timestamp":1784872379302,"version":"3.55.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.neuroscience.2021.01.003","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:49:59Z","timestamp":1610930999000},"page":"120-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke"],"prefix":"10.1016","volume":"460","author":[{"given":"Sofiyan","family":"Saleem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tieqiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy L.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2021.01.003_b0005","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1097\/00001756-200109170-00050","article-title":"Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia","volume":"12","author":"Asahi","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0010","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.21-19-07724.2001","article-title":"Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia","volume":"21","author":"Asahi","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0015","first-page":"29","article-title":"New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression","volume":"1825","author":"Bauvois","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0020","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1038\/onc.2017.118","article-title":"CYP4A in tumor-associated macrophages promotes pre-metastatic niche formation and metastasis","volume":"36","author":"Chen","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0025","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/nm1498","article-title":"Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage","volume":"12","author":"Cheng","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0030","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1460-9568.2011.07843.x","article-title":"Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse","volume":"34","author":"Copin","year":"2011","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0035","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.expneurol.2008.05.022","article-title":"Delayed matrix metalloproteinase inhibition reduces intracerebral hemorrhage after embolic stroke in rats","volume":"213","author":"Copin","year":"2008","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/157489207780832423","article-title":"Mechanisms to inhibit matrix metalloproteinase activity: where are we in the development of clinically relevant inhibitors?","volume":"2","author":"Corbitt","year":"2007","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0045","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2165\/11318390-000000000-00000","article-title":"Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility","volume":"70","author":"Dorm\u00e1n","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/01.STR.0000251644.76546.62","article-title":"Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry","volume":"38","author":"Dzialowski","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0055","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12975-012-0222-5","article-title":"Recommendations for preclinical research in hemorrhagic transformation","volume":"4","author":"Fagan","year":"2013","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0006-8993(99)01843-0","article-title":"Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion","volume":"842","author":"Fujimura","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.pjnns.2014.07.012","article-title":"The rtPA increases MMP-9 activity in serum during ischaemic stroke","volume":"48","author":"Go\u0142\u0105b","year":"2014","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0070","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1517\/14728222.12.2.159","article-title":"Tissue-type plasminogen activator as a therapeutic target in stroke","volume":"12","author":"Gravanis","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0075","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s12975-018-0644-9","article-title":"PAI-1 but Not PAI-2 gene deficiency attenuates ischemic brain injury after experimental stroke","volume":"10","author":"Griemert","year":"2019","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0080","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","author":"Group TNIoNDaSr-PSS","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0085","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1523\/JNEUROSCI.1563-05.2005","article-title":"A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia","volume":"25","author":"Gu","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0090","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/STROKEAHA.111.623033","article-title":"Improved prediction of poor outcome after thrombolysis using conservative definitions of symptomatic hemorrhage","volume":"43","author":"Gumbinger","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0095","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/01.STR.0000073788.81170.1C","article-title":"Increase in plasma matrix metalloproteinase-9 in acute stroke patients with thrombolysis failure","volume":"34","author":"Heo","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0100","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.STR.0000088062.86084.F2","article-title":"Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies","volume":"34","author":"Horstmann","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.expneurol.2014.02.009","article-title":"Reversing the deleterious effects of alpha2-antiplasmin on tissue plasminogen activator therapy improves outcomes in experimental ischemic stroke","volume":"255","author":"Houng","year":"2014","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0110","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.02.006","article-title":"Asymptomatic intracerebral hemorrhage may worsen clinical outcomes in acute ischemic stroke patients undergoing thrombectomy","volume":"28","author":"Jiang","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/jcbfm.2013.203","article-title":"Hemorrhagic transformation after ischemic stroke in animals and humans","volume":"34","author":"Jickling","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0120","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.nbd.2010.03.008","article-title":"Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator","volume":"38","author":"Jin","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0125","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/CIRCULATIONAHA.108.845461","article-title":"Platelet dense-granule secretion plays a critical role in thrombosis and subsequent vascular remodeling in atherosclerotic mice","volume":"120","author":"King","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1055\/s-0038-1653411","article-title":"Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro","volume":"46","author":"Korninger","year":"1981","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.matbio.2009.01.001","article-title":"Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis","volume":"28","author":"Kyriakides","year":"2009","journal-title":"Matrix Biol"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0140","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1161\/01.STR.31.12.3034","article-title":"Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke","volume":"31","author":"Lapchak","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0145","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1160\/TH14-01-0007","article-title":"Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke","volume":"112","author":"Lenglet","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0150","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/STROKEAHA.120.029395","article-title":"Matrix metalloproteinase-9 and monocyte chemoattractant protein-1 are associated with collateral status in acute ischemic stroke with large vessel occlusion","volume":"51","author":"Mechtouff","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0155","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1161\/hs1201.99512","article-title":"Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke","volume":"32","author":"Montaner","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0160","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.thromres.2010.02.015","article-title":"Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism","volume":"125","author":"M\u00fchl","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0165","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/mp.53.3.111","article-title":"Monoclonal antibodies","volume":"53","author":"Nelson","year":"2000","journal-title":"Mol Pathol"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0170","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/jcbfm.2014.99","article-title":"Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?","volume":"34","author":"Niego","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0175","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1212\/01.wnl.0000216133.98416.b4","article-title":"Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke","volume":"66","author":"Ning","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.10.008","article-title":"Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review","volume":"20","author":"Ramos-Fernandez","year":"2011","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0185","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1161\/STROKEAHA.114.005135","article-title":"Defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the National Institute of Neurological Disorders and Stroke tissue-type plasminogen activator trials","volume":"45","author":"Rao","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0190","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/neurintsurg-2019-014898","article-title":"The impact of general anesthesia, baseline ASPECTS, time to treatment, and IV tPA on intracranial hemorrhage after neurothrombectomy: pooled analysis of the SWIFT PRIME, SWIFT, and STAR trials","volume":"12","author":"Raychev","year":"2020","journal-title":"J Neurointerv Surg"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0195","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1212\/01.wnl.0000247064.53130.91","article-title":"New-onset hypertension and inflammatory response\/poor outcome in acute ischemic stroke","volume":"67","author":"Rodriguez-Yanez","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0200","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/01.STR.29.5.1020","article-title":"Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size","volume":"29","author":"Romanic","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0205","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/01.STR.0000170641.01047.cc","article-title":"A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke","volume":"36","author":"Rosell","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0210","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/STROKEAHA.107.500868","article-title":"MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke","volume":"39","author":"Rosell","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0215","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.coph.2007.12.001","article-title":"Multiphasic roles for matrix metalloproteinases after stroke","volume":"8","author":"Rosell","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0220","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/01.STR.0000223001.06264.af","article-title":"Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke","volume":"37","author":"Rosell","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0225","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.neuroscience.2009.02.039","article-title":"Lipocalin-prostaglandin D synthase is a critical beneficial factor in transient and permanent focal cerebral ischemia","volume":"160","author":"Saleem","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0230","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuroscience.2017.12.021","article-title":"Matrix metalloproteinase-9 mediates the deleterious effects of alpha2-antiplasmin on blood-brain barrier breakdown and ischemic brain injury in experimental stroke","volume":"376","author":"Singh","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0235","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1111\/jth.13390","article-title":"Physiologic variations in blood plasminogen levels affect outcomes after acute cerebral thromboembolism in mice: a pathophysiologic role for microvascular thrombosis","volume":"14","author":"Singh","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0240","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1468-1331.2006.01280.x","article-title":"Inflammatory biomarkers in blood of patients with acute brain ischemia","volume":"13","author":"Sotgiu","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0245","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/hs0302.104542","article-title":"Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats","volume":"33","author":"Sumii","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0250","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neuroscience.2012.03.036","article-title":"Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion","volume":"212","author":"Suofu","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0255","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/jcbfm.2013.148","article-title":"Alteplase treatment does not increase brain injury after mechanical middle cerebral artery occlusion in the rat","volume":"33","author":"Sutherland","year":"2013","journal-title":"J Cereb Blood Flow Metabol"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0260","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1538-7836.2007.02628.x","article-title":"Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice","volume":"5","author":"Suzuki","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0265","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/jcbfm.1990.47","article-title":"A semiautomated method for measuring brain infarct volume","volume":"10","author":"Swanson","year":"1990","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0270","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrd4390","article-title":"Is there new hope for therapeutic matrix metalloproteinase inhibition?","volume":"13","author":"Vandenbroucke","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0275","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/j.bmc.2007.01.011","article-title":"Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs","volume":"15","author":"Verma","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0280","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1515\/CCLM.2006.079","article-title":"Matrix metalloproteinases and their inhibitors in different acute stroke subtypes","volume":"44","author":"Vukasovic","year":"2006","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0285","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nm926","article-title":"Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator","volume":"9","author":"Wang","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0290","article-title":"Thrombolysis for acute ischaemic stroke","volume":"7","author":"Wardlaw","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0295","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/jamaneurol.2014.1210","article-title":"Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: a review of natural history and treatment","volume":"71","author":"Yaghi","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0300","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002230","article-title":"Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target","volume":"3","author":"Yu","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0305","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0165-0270(02)00114-0","article-title":"A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia","volume":"117","author":"Zhang","year":"2002","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0310","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nm1387","article-title":"Role of matrix metalloproteinases in delayed cortical responses after stroke","volume":"12","author":"Zhao","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.neuroscience.2021.01.003_b0315","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/17460441.2018.1398732","article-title":"Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer","volume":"13","author":"Zhong","year":"2018","journal-title":"Expert Opin Drug Discov"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452221000087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452221000087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:03:10Z","timestamp":1759680190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452221000087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":63,"alternative-id":["S0306452221000087"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2021.01.003","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2021.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd on behalf of IBRO.","name":"copyright","label":"Copyright"}]}}